Cytodyn Inc (CYDY)

[Grip it and Sip It]

Agreed Saltz but I think the CV19 window is shrinking. In doing some research, there are several companies on the radar getting far more attention and are uplisted already. In contrast, look at SRNE. Price target of $24, on NASDAQ, $1.2B MC with a third of shares.

Being touted as “game-changer” and if you read their board, you’d think you’re on the CYDY board. I did sell some of those shares and picked up CYDY for $2.89 this morning because I think it’s a long play.
I still stand with my personal opinion that Nader is a liability to this company. He just can not deliver, ever! Still waiting on the NEJM article which he said would be out weeks ago, only to learn it takes a while to be peer-reviewed.

All this this talk about many companies interested....how long have we heard that. Serious buyers know the value and come to the table to make a deal. Has Nader priced out of the market? Is he too difficult to deal with? Lord knows he chased enough people out in the last couple years....people that he brought in.

Praying for the best but he needs to deliver something fast or I think we go back to being a cancer play and lose the CV19 premium this SP is carrying now.

All the best

Grip